Home › NDC Lookup › RxCUI directory › RxCUI 308048

Alprazolam 0.5 MG Oral Tablet — RxCUI 308048

RxNorm drug concept · Semantic clinical drug
RxCUI 308048 Semantic clinical drug · SCD ● Current RxNorm concept 66 FDA products 208 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI308048
Official nameAlprazolam 0.5 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped66
Package NDCs mapped208
Reported Medicaid activity (SDUD)2,760,361 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Alprazolam: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Alprazolam is used to treat generalized anxiety disorder (GAD) and panic disorder — including panic disorder that involves a fear of being in public places (agoraphobia). Different...
  • It can, especially when you first start taking it or if your dose changes. Sedation, sleepiness, and memory or concentration issues are among the most commonly reported side effect...
  • Will alprazolam make me feel drowsy or foggy?
  • Please don't stop on your own — this is really important. Your body can become physically dependent on alprazolam even after short-term use, and stopping suddenly can trigger serio...
📖 Read our full Alprazolam guide →

🕸️ Concept Web — How Alprazolam 0.5 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Alprazolam 0.5 MG Oral Tablet RxCUI 308048

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Alprazolam 596
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Xanax 202363
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Alprazolam Oral Tablet 370548
    • Alprazolam Oral Product 1155284
    • Alprazolam Pill 1155285
    • Alprazolam Oral Tablet [Xanax] 94610
    • Xanax Oral Product 1186300
    • Xanax Pill 1186301
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Alprazolam 0.5 MG SCDC · 317289
  • Alprazolam Oral Tablet SCDF · 370548
  • Alprazolam Oral Product SCDG · 1155284
  • Alprazolam Pill SCDG · 1155285

Brand-Name Concepts

  • Alprazolam 0.5 MG Oral Tablet [Xanax] SBD · 141928
  • Alprazolam 0.5 MG [Xanax] SBDC · 564722
  • Alprazolam Oral Tablet [Xanax] SBDF · 94610
  • Xanax Oral Product SBDG · 1186300
  • Xanax Pill SBDG · 1186301
  • Xanax BN · 202363

📦 FDA Products & Package NDCs

66 products · 208 package NDCs
208 package NDCs map to RxCUI 308048 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
59762-3721-04 1000 TABLET in 1 BOTTLE (59762-3721-4) Alprazolam Mylan Pharmaceuticals Inc. 1981-10-16
59762-3722-01 100 TABLET in 1 BOTTLE (59762-3722-1) Alprazolam Mylan Pharmaceuticals Inc. 1981-10-16
59762-3722-03 500 TABLET in 1 BOTTLE (59762-3722-3) Alprazolam Mylan Pharmaceuticals Inc. 1981-10-16
60687-0377-01 100 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-377-01) / 1 TAB... Alprazolam American Health Packaging 2023-11-09
60687-0388-01 100 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-388-01) / 1 TAB... Alprazolam American Health Packaging 2024-02-07
63187-0225-30 30 TABLET in 1 BOTTLE (63187-225-30) Alprazolam Proficient Rx LP 2014-03-03
63187-0225-60 60 TABLET in 1 BOTTLE (63187-225-60) Alprazolam Proficient Rx LP 2014-03-03
63187-0225-90 90 TABLET in 1 BOTTLE (63187-225-90) Alprazolam Proficient Rx LP 2014-03-03
63187-0443-30 30 TABLET in 1 BOTTLE (63187-443-30) Alprazolam Proficient Rx LP 2014-03-03
63187-0443-60 60 TABLET in 1 BOTTLE (63187-443-60) Alprazolam Proficient Rx LP 2014-03-03
63187-0443-90 90 TABLET in 1 BOTTLE (63187-443-90) Alprazolam Proficient Rx LP 2014-03-03
63187-0444-30 30 TABLET in 1 BOTTLE (63187-444-30) Alprazolam Proficient Rx LP 2014-03-03
63187-0444-60 60 TABLET in 1 BOTTLE (63187-444-60) Alprazolam Proficient Rx LP 2014-03-03
63187-0444-90 90 TABLET in 1 BOTTLE (63187-444-90) Alprazolam Proficient Rx LP 2014-03-03
65862-0676-01 100 TABLET in 1 BOTTLE (65862-676-01) Alprazolam Aurobindo Pharma Limited 2015-07-31
65862-0676-05 500 TABLET in 1 BOTTLE (65862-676-05) Alprazolam Aurobindo Pharma Limited 2015-07-31
65862-0676-99 1000 TABLET in 1 BOTTLE (65862-676-99) Alprazolam Aurobindo Pharma Limited 2015-07-31
65862-0677-01 100 TABLET in 1 BOTTLE (65862-677-01) Alprazolam Aurobindo Pharma Limited 2015-07-31
65862-0677-05 500 TABLET in 1 BOTTLE (65862-677-05) Alprazolam Aurobindo Pharma Limited 2015-07-31
65862-0677-99 1000 TABLET in 1 BOTTLE (65862-677-99) Alprazolam Aurobindo Pharma Limited 2015-07-31
65862-0678-01 100 TABLET in 1 BOTTLE (65862-678-01) Alprazolam Aurobindo Pharma Limited 2015-07-31
65862-0678-05 500 TABLET in 1 BOTTLE (65862-678-05) Alprazolam Aurobindo Pharma Limited 2015-07-31
65862-0678-99 1000 TABLET in 1 BOTTLE (65862-678-99) Alprazolam Aurobindo Pharma Limited 2015-07-31
65862-0679-01 100 TABLET in 1 BOTTLE (65862-679-01) Alprazolam Aurobindo Pharma Limited 2015-07-31
65862-0679-05 500 TABLET in 1 BOTTLE (65862-679-05) Alprazolam Aurobindo Pharma Limited 2015-07-31
65862-0679-99 1000 TABLET in 1 BOTTLE (65862-679-99) Alprazolam Aurobindo Pharma Limited 2015-07-31
67046-0154-03 30 TABLET in 1 BLISTER PACK (67046-0154-3) Alprazolam Coupler LLC 2026-04-29
67544-0347-15 15 TABLET in 1 BOTTLE (67544-347-15) Alprazolam Aphena Pharma Solutions - Tennessee, LLC 2006-06-22
67544-0347-30 30 TABLET in 1 BOTTLE (67544-347-30) Alprazolam Aphena Pharma Solutions - Tennessee, LLC 2005-06-23
67544-0347-45 45 TABLET in 1 BOTTLE (67544-347-45) Alprazolam Aphena Pharma Solutions - Tennessee, LLC 2006-07-13
67544-0347-53 60 TABLET in 1 BOTTLE (67544-347-53) Alprazolam Aphena Pharma Solutions - Tennessee, LLC 2005-06-23
67544-0347-60 90 TABLET in 1 BOTTLE (67544-347-60) Alprazolam Aphena Pharma Solutions - Tennessee, LLC 2005-09-20
67544-0347-70 120 TABLET in 1 BOTTLE (67544-347-70) Alprazolam Aphena Pharma Solutions - Tennessee, LLC 2005-11-02
67544-0347-75 150 TABLET in 1 BOTTLE (67544-347-75) Alprazolam Aphena Pharma Solutions - Tennessee, LLC 2006-07-20
67544-0347-80 180 TABLET in 1 BOTTLE (67544-347-80) Alprazolam Aphena Pharma Solutions - Tennessee, LLC 2006-06-01
67544-0347-90 240 TABLET in 1 BOTTLE (67544-347-90) Alprazolam Aphena Pharma Solutions - Tennessee, LLC 2006-06-01
67544-0414-15 15 TABLET in 1 BOTTLE (67544-414-15) Alprazolam Aphena Pharma Solutions - Tennessee, LLC 2006-06-16
67544-0414-30 30 TABLET in 1 BOTTLE (67544-414-30) Alprazolam Aphena Pharma Solutions - Tennessee, LLC 2005-06-30
67544-0414-45 45 TABLET in 1 BOTTLE (67544-414-45) Alprazolam Aphena Pharma Solutions - Tennessee, LLC 2006-06-01
67544-0414-53 60 TABLET in 1 BOTTLE (67544-414-53) Alprazolam Aphena Pharma Solutions - Tennessee, LLC 2005-06-30
67544-0414-60 90 TABLET in 1 BOTTLE (67544-414-60) Alprazolam Aphena Pharma Solutions - Tennessee, LLC 2005-06-23
67544-0414-70 120 TABLET in 1 BOTTLE (67544-414-70) Alprazolam Aphena Pharma Solutions - Tennessee, LLC 2005-09-07
67544-0414-80 180 TABLET in 1 BOTTLE (67544-414-80) Alprazolam Aphena Pharma Solutions - Tennessee, LLC 2008-02-22
67544-0415-15 15 TABLET in 1 BOTTLE (67544-415-15) Alprazolam Aphena Pharma Solutions - Tennessee, LLC 2006-05-10
67544-0415-20 20 TABLET in 1 BOTTLE (67544-415-20) Alprazolam Aphena Pharma Solutions - Tennessee, LLC 2010-04-26
67544-0415-30 30 TABLET in 1 BOTTLE (67544-415-30) Alprazolam Aphena Pharma Solutions - Tennessee, LLC 2005-06-23
67544-0415-45 45 TABLET in 1 BOTTLE (67544-415-45) Alprazolam Aphena Pharma Solutions - Tennessee, LLC 2006-05-25
67544-0415-53 60 TABLET in 1 BOTTLE (67544-415-53) Alprazolam Aphena Pharma Solutions - Tennessee, LLC 2005-06-23
67544-0415-55 75 TABLET in 1 BOTTLE (67544-415-55) Alprazolam Aphena Pharma Solutions - Tennessee, LLC 2010-04-26
67544-0415-60 90 TABLET in 1 BOTTLE (67544-415-60) Alprazolam Aphena Pharma Solutions - Tennessee, LLC 2005-06-23
Observed labelers: Aphena Pharma Solutions - Tennessee, LLC (35) · Bryant Ranch Prepack (20) · ASCLEMED USA INC. (16) · Asclemed USA, Inc. (16) · Proficient Rx LP (15) · Aurobindo Pharma Limited (12) · +18 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.